Table 3 Comparisons between survival and deceased patients in NEC patients
Variables | Survival, n = 87 | Deceased, n = 19 | P-value |
|---|---|---|---|
Age at diagnosis, weeks | 45.79 ± 24.36 | 57.10 ± 22.25 | 0.066 |
Gender, female (%) | 38 (43.68) | 7 (36.84) | 0.324 |
Gestational age, weeks | 30.97 ± 4.97 | 31.36 ± 4.57 | 0.753 |
Birth weight, kg | 2.77 ± 0.76 | 2.64 ± 0.73 | 0.497 |
1-min Apgar score | 6.98 ± 1.38 | 6.89 ± 1.41 | 0.790 |
5-min Apgar score | 8.11 ± 1.36 | 7.78 ± 1.39 | 0.351 |
Delivery mode, n (%) | 0.177 | ||
Vaginal delivery | 54 (62.06) | 10 (52.63) | |
Caesarean delivery | 33 (37.93) | 9 (47.37) | |
Surgery methods, n (%) | 0.128 | ||
Laparotomy | 41 (47.13) | 11 (57.89) | |
Peritoneal Drainage | 46 (52.87) | 8 (42.11) | |
HMGB1, pg/ml | 133.06 ± 59.41 | 445.29 ± 168.37 | < 0.001 |
I-FABP, ng/ml | 17.99 ± 4.42 | 34.65 ± 9.06 | < 0.001 |
CRP, pg/ml | 492.02 ± 179.51 | 482.41 ± 164.81 | 0.831 |
IL-1β, pg/ml | 70.22 ± 21.14 | 118.86 ± 45.22 | < 0.001 |
IL-6, pg/ml | 78.63 ± 33.00 | 131.21 ± 55.80 | < 0.001 |
TNF-α, pg/ml | 458.62 ± 177.42 | 505.81 ± 180.03 | 0.297 |